Fujifilm (OTCMKTS:FUJIY) Sees Unusually-High Trading Volume - Here's Why

Key Points

• Fujifilm Holdings Corp. experienced an increase in trading volume, with approximately 287,488 shares traded, marking a 23% rise from the previous session.
• Wall Street analysts have downgraded Fujifilm's stock rating from "buy" to "hold," although the company maintains a consensus rating of "buy" overall.
• The company reported a quarterly earnings per share of $0.15, in line with analysts' expectations, and had a revenue of $5.08 billion for the quarter.

Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 287,488 shares were traded during mid-day trading, an increase of 23% from the previous session's volume of 232,937 shares.The stock last traded at $11.85 and had previously closed at $12.11.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered shares of Fujifilm from a "buy" rating to a "hold" rating in a research note on Friday, May 23rd.

Fujifilm Price Performance

The company has a current ratio of 1.40, a quick ratio of 0.92 and a debt-to-equity ratio of 0.14. The company's fifty day moving average is $10.84 and its two-hundred day moving average is $10.49. The stock has a market cap of $30.55 billion, a price-to-earnings ratio of 11.06, a P/E/G ratio of 3.72 and a beta of 0.67.

Fujifilm (OTCMKTS:FUJIY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The technology company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $760.41 billion. Fujifilm had a net margin of 7.93% and a return on equity of 7.73%. As a group, research analysts predict that Fujifilm Holdings Corp. will post 0.66 earnings per share for the current year.

Fujifilm Company Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.